3D Printing Technology for Pharmaceutical and Biomedical Application
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 57723
Special Issue Editor
Special Issue Information
Dear Colleagues,
Three-dimensional printing technology is expanding its scope in various medical fields, such as pharmacy and biomedical engineering, and the number of papers has increased rapidly over the past five years. Since 3D printers can be used for on-demand manufacturing, they are expected to be applied to personalized medicine for each patient, and the model of medicine with unique shapes and structures based on unique concepts have been reported.
This Special Issue invites research on various medicines and instruments related to 3D printers. For example, medicines in various dosage forms based on a unique concept created with a 3D printer, medicines for elderly and pediatric patients who do not meet their needs, special devices for administering drugs, functional materials suitable for modeling with various 3D printers, special 3D printer parts suitable for manufacturing special pharmaceutical products, quality control research necessary for manufacturing 3D printers in future pharmaceutical factories and medical institutions, and fusion of advanced technologies (such as information technology and 3D printers) are applicable.
Original research articles and reviews are welcome. I look forward to receiving your contributions.
Dr. Tatsuaki Tagami
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 3D printing of personalized medicine
- 3D printing of medical device
- functional materials for various types of 3D printer
- quality control for 3D printing of pharmaceuticals
- fusion of 3D printing and other technology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.